Terns Pharmaceuticals, Inc.

NASDAQ:TERN

4.66 (USD) • At close February 5, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Omzet 0001.3220000000100000000
Kosten van de omzet 00.240.2360.220.2220.2170.2220.4850.2520.2690.2780.1140.1070.1190.17200000
Brutowinst 0-0.24-0.2361.102-0.222-0.217-0.222-0.485-0.252-0.269-0.2780.886-0.107-0.119-0.17200000
Brutowinstmarge 0000.83400000000.88600000000
Onderzoek- en ontwikkelingskosten 15.16918.35218.58717.45914.83114.15117.05610.65812.1618.6628.1369.4627.1535.9618.7357.775.4047.6117.2447.556
Algemene en administratieve kosten 9.777.1856.8596.59918.3537.0087.1016.175.1315.4225.6895.4164.7154.8574.5610.9983.3332.4862.1792.388
Verkoop- en marketingkosten 00-0.236-0.220000000000000000
Verkoop-, algemene en administratieve kosten 9.777.1856.6236.37918.3537.0087.1016.175.1315.4225.6895.4164.7154.8574.5610.9983.3332.4862.1792.388
Overige kosten 00-0.012-0.245-0.005-0.06-0.004-0.004-0.014-0.0540.0040.010.0040.039-0.013-0.747-2.7530.250.1670.139
Bedrijfskosten 24.93925.53725.2123.83833.18421.15924.15716.82817.29214.08413.82514.87811.86810.81813.2968.7688.73710.0979.4239.944
Bedrijfsresultaat -24.939-25.537-25.446-24.058-33.184-21.159-24.157-16.828-17.292-14.084-13.825-13.878-11.868-10.818-13.296-8.768-8.737-10.097-9.423-9.944
Bedrijfsresultaat ratio 000-18.1980000000-13.87800000000
Totaal overige inkomsten en kosten netto 3.0562.8623.173.0883.4753.3352.6891.3240.4850.160.0730.0650.0530.094-0.002-0.45-2.7520.2520.217-0.1
Inkomen voor belasting -21.883-22.675-22.276-20.97-29.709-17.824-21.468-15.504-16.807-13.924-13.752-13.813-11.815-10.724-13.298-9.218-11.489-9.845-9.206-10.044
Inkomen voor belasting ratio 000-15.8620000000-13.81300000000
Belastingkosten 0.0620.0610.0970.0490.0580.0720.060.3180.0130.0060.0210.4350.020.0140.0390.7110.102-0.159-0.2550.002
Nettowinst -21.945-22.736-22.373-21.019-29.767-17.896-21.528-15.822-16.82-13.93-13.773-14.248-11.835-10.738-13.337-9.929-11.435-9.688-9.001-9.775
Nettowinstmarge 000-15.8990000000-14.24800000000
WPA (Winst Per Aandeel) -0.28-0.31-0.3-0.29-0.42-0.25-0.31-0.29-0.44-0.55-0.55-0.56-0.47-0.43-0.88-0.65-0.48-0.4-0.38-0.41
Verwaterde WPA -0.28-0.31-0.3-0.29-0.42-0.25-0.31-0.29-0.44-0.55-0.55-0.56-0.47-0.43-0.88-0.65-0.48-0.4-0.38-0.41
EBITDA -24.733-25.297-25.364-23.986-33.112-21.159-24.157-16.586-17.04-13.815-13.474-13.764-11.761-10.699-13.124-8.662-8.636-9.998-9.335-9.625
EBITDA ratio 000-18.0320000000-13.87800000000